|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 883.75 INR | -1.88% |
|
-4.72% | -3.35% |
| Jan. 13 | US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease | RE |
| Jan. 13 | Zydus Lifesciences Receives US FDA Nod for Rare Pediatric Disease Drug | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 920.25 | 977.3 | 1,044.75 |
| Spread/Res. | -3.97% | -9.57% | -15.41% |
| Spread/Supp. | -1.25% | -1.25% | +6.28% |
| Support | 894.9 | 894.9 | 831.55 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- Charts Zydus Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions
